🔗 Share this article

Treasury head Rachel Reeves has announced she is planning "specific steps to tackle household expense challenges" in the upcoming financial statement.

Speaking to media outlets, she stated that lowering inflation is a shared duty of both the administration and the Bank of England.

The UK's price growth is projected to be the most elevated among the G7 developed nations this year and the following year.

Potential Utility Bill Interventions

It is understood the government could take action to reduce utility costs, for example by slashing the present 5% rate of VAT applied on energy supplies.

An additional option is to lower some of the government charges presently added to bills.

Fiscal Constraints and Analyst Predictions

The administration will obtain the next draft from the official forecaster, the OBR, on the start of the week, which will reveal how much scope there is for these actions.

The consensus from most economists is that the Chancellor will have to declare tax increases or spending cuts in order to fulfill her self-imposed debt limits.

Previously on Thursday, calculations showed there was a £22 billion shortfall for the chancellor to fill, which is at the lower end of forecasts.

"There's a shared responsibility between the Bank of England and the government to further reduce some of the drivers of inflation," Reeves informed reporters in the US capital, at the conferences of the IMF and World Bank.

Tax Pledges and Global Concerns

While much of the attention has been on probable tax increases, the chancellor said the most recent data from the fiscal watchdog had not altered her pledge to election pledges not to increase tax levels on income tax, sales tax or National Insurance.

She attributed an "uncertain global environment" with growing international and trade tensions for the Budget tax moves, probably to be targeted on those "wealthiest."

International Trade Disputes

Addressing concerns about the United Kingdom's economic relations with China she said: "The UK's national security always come first."

Last week's announcement by China to strengthen trade restrictions on rare earths and other materials that are key for advanced tech production led American leader Donald Trump to suggest an additional 100% import tax on goods from the Asian country, increasing the possibility of an full-scale trade war between the two global powers.

The American finance chief labeled China's action "commercial pressure" and "a global supply chain power grab."

Inquired about accepting the US offer to join its conflict with China, the Chancellor said she was "deeply worried" by Chinese actions and urged the Chinese government "to avoid restrictions and restrict access."

She said the decision was "bad for the global economy and creates further obstacles."

"It is my opinion there are areas where we must address Chinese policies, but there are also significant prospects to export to Chinese markets, including banking sector and other sectors of the economic system. We've got to achieve that equilibrium correct."

The chancellor also affirmed she was collaborating with international partners "regarding our own critical minerals strategy, so that we are less reliant."

Health Service Drug Costs and Investment

Reeves also admitted that the price the NHS pays for medicines could increase as a consequence of current negotiations with the US government and its drugs companies, in exchange for lower tariffs and investment.

Some of the world's largest pharmaceutical manufacturers have said in recent statements that they are either delaying or abandoning operations in the United Kingdom, with some blaming the low prices they are obtaining.

Recently, the government science advisor said the cost the NHS spends on medicines would must rise to stop firms and pharmaceutical investment leaving the United Kingdom.

The Chancellor informed the BBC: "It has been observed due to the payment system, that clinical trials, recent pharmaceuticals have not been offered in the UK in the manner that they are in other European countries."

"We want to guarantee that patients receiving treatment from the National Health Service are can receive the top life-saving drugs in the globe. And so we are reviewing all of that, and... seeking to secure increased capital into the UK."